Christopher Horvath
Overview
Explore the profile of Christopher Horvath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rojko J, Evans M, Price S, Han B, Waine G, DeWitte M, et al.
Toxicol Pathol
. 2014 Apr;
42(4):725-64.
PMID: 24705884
Vascular inflammation, infusion reactions, glomerulopathies, and other potentially adverse effects may be observed in laboratory animals, including monkeys, on toxicity studies of therapeutic monoclonal antibodies and recombinant human protein drugs....
2.
Ihmsen M, Cornelis J, Solenthaler B, Horvath C, Teschner M
IEEE Trans Vis Comput Graph
. 2014 Jan;
20(3):426-35.
PMID: 24434223
We propose a novel formulation of the projection method for Smoothed Particle Hydrodynamics (SPH). We combine a symmetric SPH pressure force and an SPH discretization of the continuity equation to...
3.
Horvath C, Andrews L, Baumann A, Black L, Blanset D, Cavagnaro J, et al.
Nat Rev Immunol
. 2012 Sep;
12(10):740.
PMID: 22941443
No abstract available.
4.
Bussiere J, Martin P, Horner M, Couch J, Flaherty M, Andrews L, et al.
Int J Toxicol
. 2009 Jun;
28(3):230-53.
PMID: 19546261
Although toxicology studies should always be conducted in pharmacologically relevant species, the specificity of many biopharmaceuticals can present challenges in identification of a relevant species. In certain cases, that is,...
5.
Horvath C, Welt F, Nedelman M, Rao P, Rogers C
Circ Res
. 2002 Mar;
90(4):488-94.
PMID: 11884380
A central role for leukocytes in neointimal hyperplasia after arterial injury is suspected. However, the relative importance of neutrophils and monocytes in balloon or stent-induced injury are not well understood,...
6.
Morrissey R, Horvath C, Snyder E, Patrick J, MacDonald J
Toxicol Sci
. 2002 Jan;
65(2):266-75.
PMID: 11812931
SCH 58500 is a replication-defective recombinant adenoviral vector containing the cloned human wild-type (normal) tumor suppressor gene p53. SCH 58500 is in trials to evaluate potential clinical utility. A series...
7.
Morrissey R, Horvath C, Snyder E, Patrick J, Collins N, Evans E, et al.
Toxicol Sci
. 2002 Jan;
65(2):256-65.
PMID: 11812930
Adenoviral vectors are being actively investigated for their potential utility in gene therapy. SCH 58500, a replication-deficient adenoviral vector, carries the normal p53 tumor suppressor gene, which is frequently mutated...